KRTAP13-3

Across TCGA pan-cancer cohorts, KRTAP13-3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KRTAP13-3 data layer compared with 4 for mutation status.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher KRTAP13-3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP13-3 expression acts as an unfavorable survival marker.

BRCA, LUSC, and BLCA are the cancer types where KRTAP13-3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.336	0.924	<.001	72	view →
LUSC	OS	Tertile	II,III,IV	0.073	0.733	<.001	48	view →
BLCA	OS	Tertile	IV	0.051	0.600	<.001	36	view →
STAD	OS	Tertile	All	0.444	0.735	.004	36	view →
UCEC	DFS	Tertile	All	0.077	0.648	<.001	36	view →
TGCT	DFS	Tertile	All	0.014	0.837	<.001	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
LGG	DFS	Tertile	All	0.396	0.742	.007	15	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KRTAP13-3–BRCA (OS)

Open the BRCA breakdown →